Clinical Trials

Study Title:
Randomized, Phase III Study of Early Intervention With Venetoclax and Obinutuzumab Versus Delayed Therapy With Venetoclax and Obinutuzumab in Newly Diagnosed Asymptomatic High-Risk Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): EVOLVE CLL/SLL Study

For more information about the trial above please contact the study team:

Principal Investigator, Brian Hess, at

Study Coordinator, Sarah Britton, at, or please call +1 843-792-8856.

Trial opened at the following institutions: Medical University of South Carolina